Drug Shortage Report for ALOXI
Report ID | 22982 |
Drug Identification Number | 02381710 |
Brand name | ALOXI |
Common or Proper name | Aloxi Injection |
Company Name | KNIGHT THERAPEUTICS INC. |
Market Status | MARKETED |
Active Ingredient(s) | |
Strength(s) | |
Dosage form(s) | |
Route of administration | |
Packaging size | 0.25 mg/5 mL |
ATC code | |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-09-21 |
Actual start date | 2017-09-21 |
Estimated end date | 2017-10-30 |
Actual end date | 2017-10-23 |
Shortage status | Resolved |
Updated date | 2017-10-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3400 DE MAISONNEUVE BLVD W MONTREAL, QUEBEC CANADA H3Z 3B8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-21 | English | Compare |
v2 | 2017-09-21 | French | Compare |
v3 | 2017-09-22 | English | Compare |
v4 | 2017-09-22 | English | Compare |
v5 | 2017-09-22 | French | Compare |
v6 | 2017-10-23 | English | Compare |
v7 | 2017-10-23 | French | Compare |
v8 | 2017-10-24 | English | Compare |
Showing 1 to 8 of 8